| Bicalutamide |
ENSG00000005206.12 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000088970.11 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000104691.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000104691.10 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000118412.8 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000124835.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000124835.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000124915.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000124915.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000131484.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000149656.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000152487.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000152487.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000157306.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000160336.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000166770.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000167912.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000170161.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000170161.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000170161.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000170590.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000170846.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000170846.11 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000172250.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000172965.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000172965.10 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000172965.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000173867.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000174171.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000174365.15 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000175147.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000175701.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000175772.10 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000175873.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000175967.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000176840.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000177337.3 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000177410.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000177738.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000177757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000177788.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000177853.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000178193.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000178977.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000179523.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000179743.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000179818.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000179818.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000179935.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000179935.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000180139.10 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000180458.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000180769.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000180846.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000180846.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000180846.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000181798.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000181798.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000181798.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000182021.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000182057.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000182109.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000184068.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000184274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000184324.11 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000185044.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000185044.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000185168.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000185186.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000185203.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000185203.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000185837.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000186019.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000186594.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000186842.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000187621.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000187979.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000188185.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000188365.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000189223.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000196273.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000196295.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000196421.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000196756.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000196951.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000196951.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000197210.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000197291.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000197308.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000197332.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000197332.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000197463.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000197989.9 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000198221.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000198468.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000203288.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000203327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000203362.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000203362.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000203441.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000203441.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000203496.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000203496.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000203497.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000203497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000203588.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000203650.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000203709.5 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000203739.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000203808.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000203809.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000203865.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000203987.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000203999.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000204044.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000204044.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000204055.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000204091.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000204119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000204241.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000204380.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000204588.5 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000204625.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000204706.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000204791.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000204802.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000204802.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000204815.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000204837.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000204934.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000205037.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000205266.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000205500.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000205562.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000205611.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000205885.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000205885.3 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000205890.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000206028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000206142.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000206195.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000206337.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000206337.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000206417.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000212163.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000212694.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000212978.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000213468.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000213971.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000213971.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000213971.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000213994.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000214145.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000214401.4 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000214401.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000214432.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000214650.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000214725.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000214733.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000214770.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000214770.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000214772.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000214851.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000214870.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000214894.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000214922.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000215022.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000215039.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000215244.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000215304.3 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000215394.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000215417.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000215498.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000215769.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000215769.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000215866.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000215866.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000217576.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000217576.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000218018.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000218018.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000219665.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000220161.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000222041.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000222043.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223382.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223392.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000223461.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000223461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223461.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000223462.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000223486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223511.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223511.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000223537.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000223561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223573.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000223598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223697.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000223701.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223725.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223732.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223745.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223764.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000223770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223797.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223813.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000223823.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000223834.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223842.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000223842.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000223884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223941.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000223960.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000223960.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224032.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224043.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224043.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224046.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000224077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224078.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224078.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224079.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000224079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224086.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000224086.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000224142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224157.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224209.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000224220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224220.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000224222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224238.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000224260.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224272.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224281.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224356.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224376.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224409.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000224441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224490.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224490.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000224511.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000224533.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000224541.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224609.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000224616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224616.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000224616.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224621.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000224621.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000224666.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000224699.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224699.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224713.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224738.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000224746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224750.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224843.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224934.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224934.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000224945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000224959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000224975.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000224992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000225030.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225037.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000225037.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000225039.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000225057.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225075.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000225077.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000225092.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000225096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225113.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225138.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000225146.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225156.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225163.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225163.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000225177.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225180.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225187.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000225194.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225203.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000225210.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225218.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000225218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000225218.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000225234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225234.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000225235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225278.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225278.3 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000225302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225329.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000225331.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000225331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225353.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225376.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225376.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000225377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225377.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000225434.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000225439.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225439.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225465.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225506.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000225506.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000225518.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225518.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000225518.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000225527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225527.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000225528.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225559.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225588.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000225595.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000225675.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225731.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225733.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000225742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225751.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000225783.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225794.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225850.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225850.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225857.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000225882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225913.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000225929.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225930.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225953.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225975.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000225975.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000225975.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000225975.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000225975.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000226007.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226009.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226029.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226101.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226149.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226149.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000226155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226287.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000226291.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000226312.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226320.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000226349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226363.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226380.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000226383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226386.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000226386.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000226416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226419.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000226455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226455.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000226471.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226471.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226472.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226562.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226562.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000226645.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000226645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000226648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226669.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226686.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226688.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226738.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000226740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226746.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226746.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226752.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226752.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000226756.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000226779.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226791.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226812.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000226824.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000226824.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000226833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226852.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226853.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226853.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000226853.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226853.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000226862.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000226872.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226876.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000226877.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226891.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226891.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226904.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226950.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000226954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000226957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227014.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000227045.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227060.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227110.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000227116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227172.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227200.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227210.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227213.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227215.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227245.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000227248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227252.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227256.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000227285.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227354.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227354.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227372.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000227373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227388.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227388.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000227388.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000227407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227407.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000227431.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227487.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227495.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000227512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227518.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227527.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227540.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000227540.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000227589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227617.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227630.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227630.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000227640.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000227646.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227740.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000227769.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227888.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227895.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227896.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227946.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000227959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000227959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000227963.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228016.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228028.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000228031.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228037.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000228060.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000228067.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228107.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000228109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228113.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228126.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000228135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000228139.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000228141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228192.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228203.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000228204.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228214.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228242.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000228251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228265.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000228271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228274.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000228274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228288.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000228293.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000228293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228302.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228315.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000228318.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228323.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000228323.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000228340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228350.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000228353.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000228355.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000228363.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000228386.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228393.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228395.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228412.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228485.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000228486.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228528.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000228566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228604.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228614.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228624.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228629.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228629.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228677.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000228680.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228686.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000228686.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228737.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000228763.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000228775.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228784.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228784.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000228794.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228826.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228852.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000228862.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228878.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228878.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000228886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228889.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228889.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228906.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000228906.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000228939.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000228972.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000228973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000228989.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000229005.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000229021.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000229065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229102.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229105.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000229109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229178.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229180.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229227.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000229243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229294.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000229463.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000229494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229521.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000229521.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229521.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000229525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229525.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000229536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229582.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229587.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229628.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000229645.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000229647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229656.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000229656.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000229656.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229692.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229702.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000229702.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000229719.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000229727.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229728.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000229728.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229739.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000229832.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000229848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229862.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229950.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000229951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229953.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000229953.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000229956.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229970.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229980.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229980.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000229980.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000229999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000229999.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230074.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230102.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230155.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000230155.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230177.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000230184.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000230212.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230303.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000230303.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000230303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230314.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230333.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230337.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000230366.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230366.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230381.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000230410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230424.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000230427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230479.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000230490.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230499.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000230513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230530.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230590.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000230612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230612.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000230613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230648.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230676.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230679.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230729.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230731.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000230735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230735.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230736.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230790.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230825.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000230844.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000230844.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230850.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230850.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000230880.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230880.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230899.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000230906.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230910.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230925.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000230925.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000230928.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000230939.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231028.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000231050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231050.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000231057.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000231064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231079.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231081.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000231125.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000231128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231154.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000231154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231154.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000231185.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000231227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231242.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000231249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231298.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231305.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231305.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231329.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000231355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231437.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231439.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231439.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231465.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231473.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231473.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231512.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000231521.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000231527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231536.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000231563.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231566.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000231595.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000231595.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231607.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231616.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231616.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000231616.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000231628.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000231636.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231652.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000231703.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231728.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231731.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000231764.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231769.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231769.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000231816.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000231817.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000231830.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231830.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000231840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231842.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000231842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231856.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231856.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231856.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000231871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231908.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000231908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000231999.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000231999.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000232023.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232043.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000232044.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232046.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232063.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000232063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232063.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000232065.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000232065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232065.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000232082.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000232093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232098.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232104.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232118.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000232160.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232164.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000232194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232233.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000232233.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000232295.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000232300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232300.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232310.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000232336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232336.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000232363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232396.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232485.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232485.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000232490.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000232530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232533.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000232542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232564.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000232564.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000232586.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000232586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000232593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232640.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232640.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000232645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232645.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000232656.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000232677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232693.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000232710.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232729.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232732.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232739.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232803.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232860.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232876.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000232909.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232931.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000232934.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000232936.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000232940.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000232956.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000232986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232987.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000232995.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000232995.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233016.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233016.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000233038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233064.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233077.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000233080.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233080.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233110.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000233144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000233154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233178.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233203.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000233220.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233242.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233246.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000233246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233246.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000233290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233330.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000233360.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000233360.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233363.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233396.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233411.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000233427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233431.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233483.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000233496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233527.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000233547.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000233559.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000233593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233602.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000233621.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000233654.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000233661.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233672.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233723.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233757.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233757.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000233785.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000233791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000233871.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000233871.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000233926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000233953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234019.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234028.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234062.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234062.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000234062.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000234084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000234134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234134.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000234141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234171.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234183.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234206.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000234225.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234281.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234352.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234394.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234432.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234478.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000234478.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000234494.3 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000234503.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234509.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234509.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000234608.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234616.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234661.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234665.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234665.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234676.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234684.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234690.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234690.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000234690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234695.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000234705.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000234705.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000234707.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000234722.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000234740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234741.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234741.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000234771.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234883.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000234883.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234892.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234912.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000234912.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234936.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000234943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000234978.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000234996.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000234996.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000234996.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000234996.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000235024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235052.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235092.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235092.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235100.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235100.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235100.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000235117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235214.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000235244.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235244.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235245.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000235257.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235269.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000235296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235314.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000235314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235419.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235475.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000235477.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235477.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000235481.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000235488.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000235494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235501.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235530.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235545.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235560.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235560.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235570.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235590.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235703.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000235706.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235724.4 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000235726.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000235760.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235760.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235770.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000235772.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000235781.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235795.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000235806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235831.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235831.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000235852.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235872.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235884.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235884.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000235888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000235890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235903.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235903.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235910.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000235919.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235919.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235927.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235954.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000235954.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000235958.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000235989.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236003.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000236051.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236088.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236107.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236206.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000236255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236305.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000236308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000236318.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000236347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000236364.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236404.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236434.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000236447.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000236449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000236501.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236502.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236540.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000236540.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000236545.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000236558.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236581.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000236617.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236663.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000236668.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236717.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236753.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000236760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236780.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236810.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236830.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236861.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000236861.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236901.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236901.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236901.3 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000236908.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000236924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000236947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000236977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237013.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000237015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237021.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237037.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237126.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237128.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000237133.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000237149.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237187.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000237188.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237200.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000237253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237291.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237298.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237338.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237359.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237359.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000237380.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237380.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237436.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237436.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237463.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237517.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237529.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237594.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237594.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237687.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000237718.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000237721.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000237737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237742.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237751.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237753.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000237768.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000237786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000237805.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000237836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237836.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000237845.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000237853.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237877.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000237883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237883.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000237883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237886.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000237892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237940.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237940.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237945.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000237976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000237978.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000237989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238005.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238009.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000238035.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000238039.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000238062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238113.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238120.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000238133.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000238140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000238186.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000238197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000238221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000238261.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000238273.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000238273.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000238287.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000238290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000239002.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000239002.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000239213.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000239219.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000239265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239335.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000239335.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000239377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000239377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239415.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000239415.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000239446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239467.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000239523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239569.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000239664.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239674.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000239774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000239774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000239920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239921.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239930.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000239945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000240005.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000240006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240006.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000240063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000240086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000240143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240219.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000240219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240219.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000240254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000240291.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000240401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240405.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000240440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240498.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240499.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240499.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000240549.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000240571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000240710.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000240710.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240758.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000240996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000240996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000241180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000241180.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000241280.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000241449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000241505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000241520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000241684.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000241818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000241832.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000241886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000241954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000242078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000242082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000242086.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000242375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000242396.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000242516.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000242553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000242553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000242569.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000242569.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000242659.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000242686.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000242686.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000242767.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000242791.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000242798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243018.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000243107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000243230.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000243319.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000243319.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000243368.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000243389.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243485.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243533.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000243766.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000243795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243797.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243819.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000243819.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000243849.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000243960.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244055.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000244124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000244184.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244184.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244184.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000244203.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000244265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244306.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244332.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000244380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244459.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244558.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000244757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244879.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244879.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244926.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000244952.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244952.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000244968.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000244968.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245112.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245149.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000245149.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000245275.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000245281.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000245293.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000245330.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000245330.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245498.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000245552.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245573.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000245598.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000245598.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000245598.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000245614.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000245685.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245748.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000245750.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245849.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000245857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000245904.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000245910.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000245937.3 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000246067.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000246089.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246090.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000246130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246174.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246250.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000246308.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246331.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000246334.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000246339.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246379.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000246379.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246451.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246465.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246465.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000246523.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246548.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246560.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000246627.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246640.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000246763.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000246790.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246792.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000246792.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246820.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000246889.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000246898.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000246982.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000247011.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247081.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000247092.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247095.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000247095.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000247131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247134.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247137.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247137.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000247151.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247151.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000247240.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247240.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247240.3 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000247324.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247324.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000247363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247373.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247373.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000247400.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247400.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247416.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247498.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247498.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000247516.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247556.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247572.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000247708.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247708.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000247774.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000247809.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000247844.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000247853.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000247950.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248049.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248092.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248100.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248103.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248103.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000248103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248187.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000248187.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000248240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248309.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248360.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000248388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000248508.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248508.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000248508.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248514.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248538.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000248559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248559.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248596.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248668.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000248668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000248671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248690.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000248714.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248740.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000248773.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000248774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248774.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248810.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000248858.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000248925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000248925.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000248996.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000249096.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000249159.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000249231.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000249249.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000249252.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000249348.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000249356.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249395.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249406.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249417.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249430.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000249487.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249509.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000249526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249550.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000249572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249592.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249602.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000249614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249655.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000249684.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000249695.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249734.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249738.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000249740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249787.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249807.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249859.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249859.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000249870.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000249899.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000249923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000249996.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000250012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000250046.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250101.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000250101.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000250132.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000250132.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250132.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000250159.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000250220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000250220.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250222.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000250230.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250244.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250286.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000250326.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000250326.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250337.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000250365.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000250366.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250404.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000250432.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000250432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250508.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000250519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250616.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250659.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000250659.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000250742.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000250764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000250765.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000250802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000250802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250802.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000250820.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000250820.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000250889.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250899.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000250903.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000250909.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000250910.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250917.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000250917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000250950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000250988.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000250990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000250999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000251015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000251054.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000251072.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000251131.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000251136.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000251161.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251175.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000251175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251194.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000251194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000251298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000251323.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251330.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000251361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251461.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000251497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251562.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000251580.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251602.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251603.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000251623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251661.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000251665.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000251666.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000251666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000251867.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253106.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253106.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000253123.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000253167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253197.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000253270.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000253327.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000253335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253390.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000253392.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253392.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253414.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000253433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253476.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000253477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253522.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000253530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253559.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253567.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253616.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253632.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253636.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000253653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253696.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000253696.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253706.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000253706.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000253716.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253736.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000253744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000253754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253773.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000253824.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000253829.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000253844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253853.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253854.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253854.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253859.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000253865.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000253875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253878.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253878.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253930.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000253930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253930.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000253948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000253948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000253972.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254042.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254129.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000254154.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254208.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254208.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000254224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254226.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000254226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254286.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000254319.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000254341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000254343.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000254353.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000254370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254428.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000254433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000254461.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000254468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254468.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000254473.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000254485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254495.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000254510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254631.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254648.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254671.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254671.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000254675.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254676.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000254682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254718.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254718.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000254756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000254777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254847.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000254855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254879.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254911.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000254911.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000254936.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000254966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255027.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255027.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255031.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000255084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255089.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255090.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000255090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255121.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255121.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255129.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255135.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255142.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000255153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000255158.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000255164.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255176.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000255182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255236.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000255237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255276.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000255310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255318.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000255334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255334.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000255355.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000255362.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255421.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000255428.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255435.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000255443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255455.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000255455.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000255458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255487.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000255495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000255496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255503.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255509.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000255517.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255545.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255557.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000255559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255559.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000255568.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255650.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000255669.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000255669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255717.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255929.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000255933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255946.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000255946.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000255989.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000255989.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000255989.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000256083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000256084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000256092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000256092.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256146.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256150.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000256150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256195.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000256196.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000256196.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000256218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256248.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000256249.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256278.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000256325.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000256360.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000256381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256433.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000256442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000256443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256481.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000256482.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000256538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000256542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000256588.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256712.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000256712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000256712.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000256725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000256747.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000256802.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000256824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000256967.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000256973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257023.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257038.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000257038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257052.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257067.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257086.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000257126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257135.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000257151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257167.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257185.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000257270.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000257272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257283.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000257285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257337.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257346.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257391.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257443.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000257449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257456.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000257458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257467.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257475.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257475.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000257496.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000257497.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000257499.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257527.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000257543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257595.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000257595.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000257596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257696.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257718.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000257742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257761.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000257761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257809.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257829.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000257829.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257894.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000257900.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000257925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000257964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000257999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258034.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000258034.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000258035.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000258050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258057.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000258082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258099.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000258101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000258136.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000258169.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258285.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000258301.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258354.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258378.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258413.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258428.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000258443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258443.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000258458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258458.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000258471.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000258515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258525.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258561.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258593.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000258620.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000258647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258667.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000258673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258701.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000258704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258730.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000258731.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000258748.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258793.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258809.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258819.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258821.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000258825.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000258825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000258857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000258858.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000258884.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000258902.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000258904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000258914.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000258927.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000258927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258935.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000258949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000258955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258982.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000258999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259036.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259084.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259088.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000259103.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259116.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000259129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259138.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259138.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259146.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259158.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000259172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259198.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000259209.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259215.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259215.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000259230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000259230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259244.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259248.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000259251.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259287.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259294.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259298.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000259345.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000259362.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259377.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000259380.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000259396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259402.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000259407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259416.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259436.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259442.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000259442.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000259445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259448.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259488.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259521.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259540.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000259542.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000259543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259548.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000259553.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259553.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000259555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259561.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259561.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259563.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000259577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259617.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000259623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000259644.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259652.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259673.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000259678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259715.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259732.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000259732.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000259735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259736.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000259736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259744.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000259758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259758.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259762.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259768.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259771.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259772.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259772.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259775.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259782.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000259783.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259783.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000259793.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000259793.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259802.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000259820.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000259826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259863.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000259867.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259883.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000259883.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259894.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259901.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000259915.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259926.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000259935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259943.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000259959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000259969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000259994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260011.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260017.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000260017.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000260018.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000260018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260059.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000260065.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000260083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260086.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000260088.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000260091.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000260095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260095.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000260101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260132.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260156.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000260158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000260163.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260167.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000260190.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000260193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260209.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260219.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000260231.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000260231.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260233.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000260285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260288.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000260293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260293.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000260296.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260306.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000260316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260316.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000260317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260331.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260336.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260337.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260351.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000260369.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260369.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260369.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000260372.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260381.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260394.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260400.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260411.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260411.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000260417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260420.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000260423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260430.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000260447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260447.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000260455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260464.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000260509.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260572.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260578.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260586.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000260588.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260597.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000260601.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260608.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260608.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260626.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260633.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260633.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260641.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260651.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260664.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000260671.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000260672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000260708.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260708.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260711.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000260735.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000260742.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000260743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260751.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260787.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000260787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000260792.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000260793.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260793.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260796.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000260804.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000260804.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260805.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260831.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260833.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000260837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260838.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260918.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000260944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000260949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000260978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000260996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000261000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261003.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261005.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000261005.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000261005.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000261008.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261008.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000261013.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261024.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261064.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261068.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000261069.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261094.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000261094.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000261096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261098.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261105.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000261124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261140.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000261159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261168.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000261168.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000261173.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000261200.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261211.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261219.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000261220.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000261242.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261254.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000261265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261267.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000261280.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000261286.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000261288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261288.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000261291.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000261302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261318.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261324.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261342.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000261342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261357.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261369.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000261373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261396.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000261407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261431.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261433.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000261435.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261441.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261455.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000261468.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000261471.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261474.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000261485.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000261496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261504.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261512.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261542.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000261570.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261572.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000261572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261596.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000261610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261613.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000261618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261673.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000261685.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261690.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000261693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261693.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000261695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261716.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261716.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000261722.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261728.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261731.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000261737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261760.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000261766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261775.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261775.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261797.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261879.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261879.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000261886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000261916.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000261971.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000261978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000261978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000262074.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262094.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000262098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262117.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262136.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000262155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262179.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262194.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000262202.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262213.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000262223.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000262228.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000262228.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000262298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000262298.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000262312.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000262339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000262410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000262482.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000262482.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000262514.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000262558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000262663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000262681.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000262714.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000262721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262768.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262810.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000262833.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000262833.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000262833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000262873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262877.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262879.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262903.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000262903.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000262921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000262951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000262951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000262979.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000263004.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000263011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263013.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263080.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000263164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263167.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000263167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263220.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263257.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263272.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263280.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000263307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263327.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000263350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263393.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000263412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263603.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000263603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263624.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000263627.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000263683.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263683.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263731.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263753.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263766.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000263786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263786.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000263843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000263874.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000263904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000263906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263916.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000263982.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000264015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264026.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000264078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264112.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000264167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264196.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000264207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000264304.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264339.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264365.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000264458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264569.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264569.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000264569.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264812.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264859.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000264920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000264920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000264964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265008.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000265010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000265010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000265142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000265148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265242.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265242.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000265334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000265399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265399.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000265443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265445.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000265451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265496.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265542.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000265625.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000265692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265749.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265749.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000265750.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000265800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000265912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000265912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000266010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000266040.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266040.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000266079.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000266126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266149.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000266236.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266256.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266304.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000266313.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266313.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266368.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266469.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000266473.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000266498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266601.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000266602.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000266717.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000266718.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266805.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000266821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266821.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000266824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000266904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000266905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000266921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266934.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000266935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266941.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000266969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000266975.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000266983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267002.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000267006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267009.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000267011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267018.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000267018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000267040.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267040.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267040.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000267054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267058.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267064.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000267073.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000267093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267117.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000267123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267128.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267144.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267150.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000267159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267163.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267191.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267194.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000267194.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000267199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267232.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267244.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267249.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000267251.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000267251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267251.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000267254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267265.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000267274.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267274.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267274.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000267277.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000267284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267296.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000267298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000267302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267304.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000267306.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267327.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000267334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267344.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000267345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267375.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000267375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000267380.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000267388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267395.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267419.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267446.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000267457.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267457.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000267470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000267481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267493.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000267498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267504.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000267504.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000267519.2 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000267532.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267565.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000267565.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267582.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000267583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267586.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000267588.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267651.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000267651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267682.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000267701.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267705.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000267714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267731.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267737.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000267750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267750.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000267751.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267751.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000267765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267776.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000267778.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267786.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267787.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267787.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000267804.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000267808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267834.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000267834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267834.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000267858.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000267858.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267868.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267874.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000267919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000267927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000267939.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268001.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000268006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000268015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268049.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000268087.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000268087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000268201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268205.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268362.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268366.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000268375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000268375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268471.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000268471.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268496.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000268496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268518.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000268530.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000268536.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000268536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268543.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000268564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000268583.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000268584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000268649.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000268670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000268686.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000268751.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000268812.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268912.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000268913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000268913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000268938.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000268945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000268947.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000269019.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269086.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269148.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000269161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000269161.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000269177.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269191.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000269194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269202.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000269290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269423.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000269423.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000269425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269444.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269473.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000269486.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000269486.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000269489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269524.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269653.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269653.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000269653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269680.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000269680.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000269688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269688.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269694.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000269696.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269720.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000269745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269814.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269834.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000269836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269843.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000269873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269873.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000269887.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000269896.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000269896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269903.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000269906.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000269908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269923.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269938.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000269940.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000269942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269956.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000269959.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000269971.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000269973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269983.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000269994.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000269997.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000269999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000270001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000270006.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000270012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000270020.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000270028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270035.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270041.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000270048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270061.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000270061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270068.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270074.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000270083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270083.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000270084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270095.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000270102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270103.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270112.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270130.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000270130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270133.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000270140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270159.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000270170.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270171.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270178.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270182.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270189.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270195.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000270210.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000270223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270246.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270246.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000270332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270332.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270361.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000270462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270522.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000270557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270604.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270681.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270681.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270704.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270755.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000270876.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000270964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000270964.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000270996.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000271009.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271032.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000271086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271147.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000271147.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271185.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000271185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271200.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271200.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000271218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000271234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000271265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271335.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000271344.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271366.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000271387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271555.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000271576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271716.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000271732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000271738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271771.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271781.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271788.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271789.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000271803.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271803.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000271815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271815.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000271830.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271833.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000271851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271889.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271921.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000271927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271927.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000271931.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000271948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271963.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271963.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271971.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271971.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000271978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000271978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000271978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271983.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000271991.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000271997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000271997.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272005.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000272005.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000272024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272030.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000272040.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272076.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000272077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000272086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272087.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272097.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000272103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272121.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000272130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272146.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000272181.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272192.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000272198.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272205.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272216.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272217.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272226.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272254.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272273.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000272301.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272304.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272312.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272328.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272338.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272368.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272369.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272370.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272371.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272386.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000272403.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272426.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272428.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272447.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000272452.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272462.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272489.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272489.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000272489.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000272505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272508.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000272508.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000272515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272516.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272518.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000272524.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272524.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272525.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000272544.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000272556.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000272558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272563.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272567.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000272576.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000272588.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272610.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272688.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272689.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272692.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000272696.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272715.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272716.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272716.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000272717.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272721.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000272732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272734.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000272764.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272782.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000272792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272799.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000272800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272828.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000272829.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272834.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000272846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272858.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272858.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000272859.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272859.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000272864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272866.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272870.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272870.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272872.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272872.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272892.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bicalutamide |
ENSG00000272905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000272931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272950.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272960.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272971.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272977.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000272979.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000272983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000272989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272993.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000272995.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273000.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000273004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273007.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000273007.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bicalutamide |
ENSG00000273008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273009.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000273009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273015.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000273018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273026.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bicalutamide |
ENSG00000273032.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000273032.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000273032.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273038.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000273038.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000273038.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000273038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273071.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273096.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000273097.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000273100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273104.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273107.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000273108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273117.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273129.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000273133.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000273137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273142.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000273145.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273145.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000273148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273148.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000273162.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273186.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000273203.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000273240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000273245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000273247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273247.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000273249.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000273270.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273287.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273297.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000273302.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bicalutamide |
ENSG00000273306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273308.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273321.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273344.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273350.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000273355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273355.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000273366.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bicalutamide |
ENSG00000273366.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000273367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273402.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273424.1 |
Predicted lncRNA |
Sarcoma |
|
| Bicalutamide |
ENSG00000273442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273447.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bicalutamide |
ENSG00000273448.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bicalutamide |
ENSG00000273454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273456.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bicalutamide |
ENSG00000273456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273456.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000273471.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273472.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273483.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bicalutamide |
ENSG00000273486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273488.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bicalutamide |
ENSG00000273492.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bicalutamide |
ENSG00000273493.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|